Literature DB >> 16087140

Vagal heart rate responses to chronic beta-blockade in human heart failure relate to cardiac norepinephrine spillover.

Toshihiko Kubo1, John D Parker, Eduardo R Azevedo, Deborah J Atchison, Gary E Newton, Peter Picton, John S Floras.   

Abstract

We have documented a pre-junctional beta-2 adrenoceptor mediated reduction in cardiac norepinephrine spillover (CNES) in heart failure patients receiving chronic beta-blockade. Our present objective was to ascertain the consequence of this decrease for vagal heart rate (HR) regulation by determining CNES, arterial baroreflex sensitivity for HR (BRS) and arterial baroreflex modulation of muscle sympathetic nerve activity (MSNA) before and upon 4 months of beta-blockade with either carvedilol or metoprolol. In 19 heart failure patients in sinus rhythm (age: 55+/-2 [mean+/-S.E.]; ejection fraction: 20+/-2%), beta-blockade increased BRS from 4.8+/-0.9 to 7.9+/-1.3 ms/mm Hg (P<0.005) but had no effect on arterial baroreflex modulation of MSNA. Changes in CNES and BRS were inversely related (r=-0.52; n=16, P<0.05). Chronic beta-blockade in heart failure augments reflex vagal control of HR at an efferent site of interaction involving blockade of cardiac sympathetic pre-junctional beta-2 adrenoceptors that facilitate NE release.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087140     DOI: 10.1016/j.ejheart.2004.10.012

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  9 in total

Review 1.  Pharmacologic modulation of parasympathetic activity in heart failure.

Authors:  Monali Y Desai; Mari A Watanabe; Abhay A Laddu; Paul J Hauptman
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

2.  Fractal properties of human heart period variability: physiological and methodological implications.

Authors:  Can Ozan Tan; Michael A Cohen; Dwain L Eckberg; J Andrew Taylor
Journal:  J Physiol       Date:  2009-06-15       Impact factor: 5.182

3.  Caffeine Enhances Heart Rate Variability in Middle-Aged Healthy, But Not Heart Failure Subjects.

Authors:  Catherine F Notarius; John S Floras
Journal:  J Caffeine Res       Date:  2012-06

Review 4.  The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction.

Authors:  John S Floras; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2015-05-13       Impact factor: 29.983

5.  Nomogram Model Based on Clinical Risk Factors and Heart Rate Variability for Predicting All-Cause Mortality in Stage 5 CKD Patients.

Authors:  Xueyan Gao; Jing Wang; Hui Huang; Xiaoxue Ye; Ying Cui; Wenkai Ren; Fangyan Xu; Hanyang Qian; Zhanhui Gao; Ming Zeng; Guang Yang; Yaoyu Huang; Shaowen Tang; Changying Xing; Huiting Wan; Lina Zhang; Huimin Chen; Yao Jiang; Jing Zhang; Yujie Xiao; Anning Bian; Fan Li; Yongyue Wei; Ningning Wang
Journal:  Front Genet       Date:  2022-05-16       Impact factor: 4.772

Review 6.  Adrenergic nervous system in heart failure: pathophysiology and therapy.

Authors:  Anastasios Lymperopoulos; Giuseppe Rengo; Walter J Koch
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 7.  Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis.

Authors:  Gail A Alvares; Daniel S Quintana; Ian B Hickie; Adam J Guastella
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

Review 8.  Relationships among norepinephrine levels, exercise capacity, and chronotropic responses in heart failure patients.

Authors:  Liza Grosman-Rimon; Evan Wright; Solomon Sabovich; Jordan Rimon; Sagi Gleitman; Doron Sudarsky; Alla Lubovich; Itzhak Gabizon; Spencer D Lalonde; Sharon Tsuk; Michael A McDonald; Vivek Rao; David Gutterman; Ulrich P Jorde; Shemy Carasso; Erez Kachel
Journal:  Heart Fail Rev       Date:  2022-03-24       Impact factor: 4.214

9.  Search for HRV-parameters that detect a sympathetic shift in heart failure patients on β-blocker treatment.

Authors:  Yanru Zhang; Olav R de Peuter; Pieter W Kamphuisen; John M Karemaker
Journal:  Front Physiol       Date:  2013-04-16       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.